Page 2 of zydus

Most Affordable Pharma Stocks in India. (Image Source: Freepik)

Cheapest pharma stocks in India

Pharma stocks are down, but is this a golden buying opportunity? With India’s booming sector and low P/E stocks in…

March 3, 2025 06:00 IST

Zydus Lifesciences, Q4 results, fourth quarter, revenue, EBITDA, profit, dividend

Zydus Lifesciences launches flu vaccine in India to combat new influenza strain

VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives.

February 26, 2025 12:11 IST

Q3FY25: Zydus Lifesciences reports rise in profit by 30 percent to Rs 1023.80 crore

The company’s Consumer Wellness business registered revenues of Rs. 448.8 crore, up 13 % y-o-y with 4.8% volume growth.

February 5, 2025 13:39 IST

Zydus Lifesciences partners with CVS Caremark for diabetes drugs template formulary

Zituvio and combination products include Zituvio (sitagliptin), Zituvimet (sitagliptin and metformin hydrochloride) and Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release…

January 7, 2025 14:52 IST

Q2FY25: Zydus Lifesciences reports profit rises 14 percent to Rs. 911 crore; R&D investments up 22 percent Q-o-Q

Q2FY25: Zydus Lifesciences reports profit rises 14% to Rs. 911 crore; R&D investments up 22% Q-o-Q

According the company’s statement, the company’s Consumer business registered revenues of Rs. 4,87.5 crore, up 12 % y-o-y. The growth…

November 12, 2024 14:29 IST

Whirlpool Corporation, Whirlpool of India, stake sale, shareholding, earnings report

Zydus Wellness posts Q2 profit jump of 254.2% at Rs 20.90 crore, revenue up 12% YoY

Zydus Wellness posted revenue from operations at Rs 492.90 crore, up 12.0 per cent as against Rs 439.90 crore during…

November 11, 2024 14:34 IST

WHO prequalifies Zydus’s Typhoid vaccine

As per GAVI (2022) it is estimated that Typhoid accounts for an estimated 11 to 21 million cases of febrile…

October 23, 2024 12:34 IST

Zydus Lifesciences completes Phase II clinical of Usnoflast to treat ALS

Zydus Lifesciences completes Phase II clinical trial of Usnoflast to treat ALS

People living with ALS have an average survival of approximately two to five years from diagnosis, with most ALS patients…

September 10, 2024 19:26 IST

Zydus Lifesciences Q1 Results: Revenue rises 21 percent to Rs 6207.5 crore; Net profit up 31 percent to Rs 1419.9 crore

Zydus Lifesciences Q1 Results: Revenue rises 21% to Rs 6207.5 crore; Net profit up 31% to Rs 1419.9 crore

Zydus Lifesciences Q1 Results: The API business registered revenues of Rs. 1,415 mn, up 2% YoY. The business accounted for…

August 9, 2024 14:51 IST

Zydus gets WHO prequalification for its key formulation to treat Kala Azar

According to WHO, there are three main forms of the disease: cutaneous leishmaniasis (CL), visceral leishmaniasis (VL), also known as…

February 25, 2024 13:40 IST

Zydus Lifesciences, Q3 earnings, quarter results, profit, revenue, EBITDA

Zydus Lifesciences posts Q3 profit rise of 26.8% at Rs 789.60 crore, revenue up 5.8% on-year

Zydus Lifesciences posted revenue from operations at Rs 4505.20 crore, up 5.8 per cent as against Rs 4257.10 crore during…

February 9, 2024 13:34 IST

Zydus Lifesciences, Zydus Lifesciences Limited, USFDA, heart failure, healthcare news, pharma news,

Zydus Lifesciences gets USFDA nod for generic formulation to treat heart failure

Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable, symptomatic chronic…

December 1, 2023 16:18 IST

Zydus Lifesciences shares soar on Q2 results; Should you buy, hold or sell Zydus stock?

Zydus Lifesciences’ share price has exhibited remarkable growth over the last one year, with an 8.05% increase in the past…

Updated: November 8, 2023 13:02 IST

Zydus Lifesciences. healthcare sector, Q2FY24 results, profit, revenue, EBITDA, India formulations, sales

Zydus Lifesciences posts Q2 profit surge of 53.2% at Rs 800.70 crore, revenue up 9.1% on-year

Zydus Lifesciences posted revenue from operations at Rs 4368.80 crore, up 9.1 per cent as against Rs 4005.50 crore during…

November 7, 2023 13:16 IST

Zydus Wellness, Zydus Wellness Q2 results, profit, revenue, EBITDA, key brands, personal care segment, digital engagement

Zydus Wellness Q2 profit falls 30.6% to Rs 5.90 crore, revenue up 2.5% on-year

Zydus Wellness posted revenue from operations at Rs 439.90 crore, up 2.5 per cent as against Rs 429.10 crore during…

November 6, 2023 15:39 IST

Zydus Lifesciences, Diabetes, Diabetes in India, generic drugs, healthcare news, pharma news,

USFDA grants approval to Zydus’ generic formulation to treat adult patients with type 2 diabetes

According to IQVIA (MAT Aug-2023), the U.S. market for DPP-IV inhibitors and their combinations is US$ 10 bn.

November 6, 2023 14:06 IST

Divi's Laboratories, Pharmaceutical, pharma industry, Q2FY24 results, profit, revenue, EBITDA

Sun Pharma and Zydus sign licensing agreement to co-market critical drug for Chronic Kidney Disease patients in India

Under the terms of this agreement, Zydus has granted Sun Pharma semi-exclusive rights to co-market the product in India.

October 30, 2023 13:23 IST

Strides Pharma, Strides Pharma Q3 results, quarter earnings, profit, revenue, EBITDA, pharmaceutical, US Business

Zydus Lifesciences begins Phase II trial of novel drug to treat fatal motor neuron disease

ALS patients experience neuroinflammation and rapid neurodegeneration leading to a steady loss of the ability to move, speak, eat and…

October 26, 2023 09:00 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

Laura Loomer said that Americans may no longer have to press a number to listen in English when calling customer care as Trump is mulling blocking outsourcing work to Indian IT companies.

Trump mulling blocking IT outsourcing, says Laura Loomer, pushes to ‘make call centres American again’

ICPC 2025: IITs struggle as colleges from Russia, Japan, and China dominate global coding contest

ICPC 2025: IITs struggle as Russia, Japan, and China dominate global coding contest

PM Modi’s refusal to back Trump’s Nobel bid led to tariffs on India: Terril Jones

World News15 min ago

American academic Terril Jones shared insights on India-US relations under Trump’s presidency. Trump’s distinctive negotiating style involved positioning himself as a global peace broker and claiming credit for a ceasefire between India and Pakistan, which was denied by PM Modi. Jones also discussed Trump’s strategy of high demands and tariffs, and China’s increasing global leadership.

View all shorts